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RISK ANALYSIS AND LONG- 
TERM SURVIVAL IN 
PATIENTS UNDERGOING 
EXTENDED RESECTION OF 
LOCALLY ADVANCED LUNG 
CANCER 
Although locally advanced lung cancer frequently necessitates xtended resec- 
tions to preserve a chance for cure, a higher morbidity is associated with 
extended resections. It is not known whether the increased morbidity is of 
relevance for the long-term outcome. It also remains unclear whether exclusion 
of certain patients according to their risk factors can diminish mortality in 
these patients. This study therefore investigated whether certain risk factors 
predispose patients undergoing extended pulmonary resections to increased 
morbidity or mortality. It also assessed the long-term survival. The cases of 126 
consecutive patients with locally advanced lung cancer (stage T3 or T4) were 
prospectively documented. S venty-five percent of the patients required an 
extended resection and 25% a nonextended resection. Extended resections were 
associated with a significantly increased overall morbidity (p < 0.002). 
However, mortality, severe complications, or multiple complications were not 
significantly increased after extended resections. No risk factor predisposed to
an increased mortality. Risk factors that were associated with particular 
postoperative complications were pathologic ergonometry (17 < 0.002), a 
positive cardiac score (t7 < 0.003), coronary artery disease (p = 0.021), and an 
increased pulmonary risk score (p < 0.05). Overall 3-year survival was 31%. 
Patients undergoing extended resections for stage T3 or T4 tumors with no 
residual tumor (70% of the patients) showed a 3-year survival of 33%. We 
conclude that postoperative mortality cannot be reduced by excluding patients 
on the basis of particular isk factors from operations that require extended 
resections. If a patient is considered to be eligible to undergo pulmonary 
resection, he or she can be considered to be eligible to undergo extended 
pulmonary resection. Because prognosis is dismal in nonresected locally 
advanced lung cancer, we recommend an aggressive surgical approach. 
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nly 25% to 30% of all patients with carcinoma of 
the lung are first seen with surgically resectable 
tumors.i, 2 In nonadvanced non-small-cell ung car- 
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cinoma surgical removal of the tumor offers a 
chance for cure with 5-year survivals of 50% to 70% 
for stage I and 30% to 40% for stage I I  lesions)' 4
However, the heterogeneous stage I I I  disease with a 
5-year survival rate of 10% deserves a differentiated 
analysis and approach. 
Whereas clinical N3 disease will interfere with any 
curative intent, no established therapeutic approach 
can be offered to patients with clinical N2, T3, or T4 
disease. This is especially true for locally advanced 
lung cancers. In these patients, frequently the con- 
cern about postoperative morbidity and mortality 
conflicts with the intent to potentially provide cure. 
Treatment herefore ranges from palliative treat- 
ment modalities uch as radiation therapy to aggres- 
sive operation. 
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Table Ia. Staging and clinical data 
Extended Nonextended 
resections resections 
Age in years (mean/range) 59 (29-77) 57 (45-79) 
Male:female 7:1 15:1 
R0 resections 66 (70%) 29 (91%) 
R1 resections 16 (17%) 2 (6%) 
R2 resections 12 (13%) 1 (3%) 
Stage T3 disease 64* 22t 
Stage T4 disease 30 10 
Stage T3/T4 disease 2.1:1 2.2:1 
Pathologic NO disease 27 (29%) 7 (22%) 
Pathologic N1 disease 28 (30%) 16 (50%) 
Pathologic N2 disease 37 (39%) 9 (28%) 
Pathologic N3 disease 2 (2%) 0 (0%) 
*Tumors in five patients intraoperatively considered asstage T3 were 
staged as T2 tumors pathologically. 
tTumors in four patients intraoperatively considered asstage T3 were 
staged as T2 tumors pathologically. 
Because the need for an extended resection can 
usually be anticipated, 5 the decision to operate on 
these patients will be strongly influenced by the 
assessment of general risk factors. The aim of this 
study was to determine the survival after extended 
pulmonary resections and whether a risk factor 
analysis could provide guidelines to reduce the 
mortality and high morbidity commonly associated 
with extended pulmonary resections. 
Material and methods 
Between Jatmary 1, 1987, and December 31, 1990, 325 
consecutive patients with carcinoma of the lung underwent 
resection and their cases were prospectively documented. A 
total of 126 patients (39%) were first seen with locally 
advanced lung cancer classified as stage T3 or T4 tumor 
during operation. These patients are the subject of this study. 
Extended resections were defined as multivisceral re- 
sections including adjacent structures. They were done if 
tumor adherence to the neighboring structures was found 
at operation. The adjacent structures included thoracic 
wall, pericardium, pulmonary artery, diaphragm, trachea, 
esophagus, atrium, and superior vena cava. 
The mean age of patients was 59 years, with a range of 
29 to 77 years. Twenty patients (16%) were older than 70 
years. There were 111 male and 15 female patients. The 
median follow-up was 37.8 months and ranged from 19 to 
70 months, with 29 patients lost to follow-up. The patients 
were censored once lost to follow-up according to the 
Kaplan-Meier method. In 64 cases the cancer was located 
on the right side and in 62 cases it was on the left side. In 
94 (75%) of 126 patients with stage T3 or T4 disease an 
extended resection was done. In the remaining 32 patients 
(25%) a nonextended resection was done (Table I). The 
patients were well matched according to age, sex, and 
pathologic features of the tumor (Table I). The histologic 
typing of tumors is shown in Table II. R0 resections are 
resections without residual tumor, R1 indicates micro- 
Table Ib. Survival according to T and N status after 
extended resection* 
Pathologic disease n (%) Three-year su vival (%) 
i"3 No 15 (31) 33 
T3 N1 19 (40) 24 
T3 N2 14 (29) 14.2 
T4 NO 6 (24) 0 
T4 N1 7 (28) 53 
T4 N2 12 (48) 16.6 
*Excluded are two patients with N2 pathologic status and five patients with 
T2 pathologic status, seven patients who died within 30 days after 
operation, and seven patients without follow-up data. 
Table II. Histopathologic typing of resected 
bronchial carcinomas 
Extended Nonextended 
resections resections 
Squamous cell carcinoma 55 21 
Adenocarcinoma 26 4 
Adenosquamous carcinoma 2 4 
Large-cell carcinoma 4 1 
Small-cell carcinoma 2* 0 
Others 5 2 
*Preoperative work-up had suggested non-small-cell lung cancer. 
scopic residual tumor, and R2 indicates gross residual 
tumor. Table III shows types of operation done and the 
involved organs in patients with extended resections. 
Extended resections were achieved by resection of 119 
adjacent organs or structures in the 94 patients undergo- 
ing extended resections. In 72 patients only one organ or 
structure was resected, in 19 patients two organs (in most 
cases the thoracic wall and pericardium) were resected, 
and in 3 patients more than two organs or structures were 
resected. In 78% of extended resections tumor invasion 
into the adjacent organ was confirmed by histologic 
examination. In the group of nonextended resections the 
overwhelming majority of operations were pneumonecto- 
mies. This was a result of either a distance of the tumor to 
the carina of less than 2 cm or extensive adherence of the 
tumor to the pulmonary artery. In four cases of nonex- 
tended resection a lobectomy was combined with a bron- 
choplastic procedure or a bronchial sleeve resection. 
These were not classified as extended resections because 
they were not multivisceral resections. 
All patients in whom the pathohistologic examination 
revealed a T3, T4, or N2 stage underwent postoperative 
percutaneous radiation therapy of the mediastinum or the 
tumor bed with a radiation dose of 50 Gy. This protocol 
has been approved by the Tumorzentrum Munich. 
The preoperative work-up consisted of routine chest 
radiographs, an electrocardiogram, bronchoscopy with 
perbronchial or intraluminal biopsies, and computed to- 
mographic scanning of the thorax and abdomen, as well as 
abdominal ultrasonography and a bone scan. For assess- 
ment of risk factors all patients had preoperative pulmo- 
nary function studies, including body plethysmography 
and preoperative measurement of resting arterial blood 
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Table I I I .  Types of operation and organs resected 
during extended resections 
Extended Nonextended Total 
Pulmonary resections 
Lobectomy 46 
Bilobectomy 7 
Pneumonectomy 41 
Total 94 
Resection extended 
by resection of 
Thoracic wall 46 
Pericardium 39 
Pulmonary artery 15 
Diaphragm 5 
Tracheajcarina 7 
Esophagus 4 
Atrium 1 
Superior vena cava/ 2 
azygos vein 
Total 119 
4 50 
0 7 
28 67 
32 126 
gas values and blood gas values under stress. To assess 
cardiac reserve bicycle ergonometry was done. Ventila- 
tion/perfusion scanning and regional studies were re- 
served for patients with forced expiratory volume in 1 
second (FEV 0 less than 1.5 L. 
All patients received preoperative training in chest 
physiotherapy. The use of chest drainages and the meth- 
ods of coughing and deep breathing were demonstrated. 
The significance of early ambulation for rapid convales- 
cence and for avoidance of cardiovascular nd pulmonary 
complications was explained. 
Risk factors 
Assessment of cardiac risks. Fifteen percent of the pa- 
tients had a recorded history of cardiac disease. This 
included a history of myocardial infarction, electrocardio- 
graphic (ECG) evidence of an infarct, or history of angina, 
arrhythmia, congestive heart failure, or valvular disease. 
Pathologic ECG alterations during bicycle ergonometry 
were found in 20% of the patients. Arterial hypertension 
was observed in 19% of the patients (defined as diastolic 
pressure >90 mm Hg). 
A patient was considered to be at minor cardiac risk 
if he or she was able to perform bicycle ergonometry at 
80 watts for 3 minutes. If the patient was not able to perform 
at this level or showed pathologic ECG alterations, he or she 
was considered to be at high cardiac risk, 
A cardiac score was designed by adding cardiac history 
(yes 1, no 0), history of coronary artery disease (yes 1, 
no 0), congestive heart failure (yes 1, no 0), history of 
myocardial infarction (yes 1, no 0), arrhythmia (yes 1, 
no 0), pathologic ECG changes on ergonometry (yes 2, 
no 0), and performance on ergonometry of less than 3 
minutes at 80 watts (yes 1, no 0). A score of 0 or 1 was 
considered to represent a low cardiac risk. 
Patients were not considered candidates for operation if
they were not able to perform bicycle ergonometry at 60 
watts for 3 minutes. 
Assessment ofpulmonary risks. Chronic obstructive pul- 
monary disease as assessed by pulmonary function tests 
Table IV. Functional parameters used to determine 
pulmonary risk score H 
Increase of 
FEV 1 VC Resting arterial Po 2 under stress 
(L) (%) Po e (ram Hg) (%) 
Score 
1 >2 >80 >70 >+10 
2 1.5-2 60-80 60-70 -+ 10 
3 <1.5 <60 <60 >-10 
was present in 64% of the patients. Nine percent of the 
patients had concomitant pneumonia in all cases classified 
as retention pneumonia because of a central ocation of 
the tumor. Thirteen percent of the patients had the 
roentgenonologic and laboratory findings of chronic lung 
emphysema. 
To assess the pulmonary risk two scores were designed. 
Pulmonary risk score I was constructed by adding emphy- 
sema (yes 1, no 0), pneumonia (yes 1, no 0), chronic 
obstructive pulmonary disease (COPD) (yes 1, no 0), 
FEV x less than 1.5 L (yes 1, no 0), vital capacity (VC) less 
than 80% (yes 1, no 0), and increase of oxygen tension 
(Po2) under 3-minute, 80-watt stress (no 1, yes 0). A score 
of 0 to 3 was considered as low risk, a score of 4 or 5 as 
intermediate, and a score higher than 5 as high risk. The 
diagnosis of COPD was established if FEV z was de- 
creased, the ratio of FEVl:forced VC was less than 75%, 
and the alveolar-arterial oxygen gradient was increased. 
Emphysema was defined as COPD with increased antero- 
posterior chest diameter on the chest radiograph in the 
absence of predominant symptoms of chronic bronchitis. 
Whereas pulmonary risk score I included anamnestic 
and functional parameters, pulmonary risk score II was 
constructed by adding the scores hown in Table IV on the 
basis of functional parameters only. In this scoring system 
a score of 4 or 5 was considered to represent low risk. 
Intermediate risk was represented by a score of 6 or 7 and 
high risk by a score from 8 to 12. A patient was not 
considered a candidate for operation that sacrificed func- 
tional lung tissue if the FEV 1 was less than 1 L. 
Other risk factors. Fifteen percent of the patients had 
diabetes and 2.5% of them were insulin dependent. Ten 
percent of the patients howed severe obesity with a body 
weight of more than 50% greater than the ideal body 
weight. In 8% of the patients renal insufficiency was 
observed (defined as serum creatinine value ---1.5 mg/dl). 
Statistical analysis. Survival (crude cumulative sur- 
vival) was calculated according to the Kaplan-Meier 
method excluding the 30-day mortality and analyzed by 
6 the log-rank test. Statistical analysis of parameters was 
done by the X 2 test with Yates' correction and one-way 
analysis of variance. Normal distribution was evaluated by 
the normal probability plot. The level of significance was 
set a tp  = 0.05. 
Results 
Postoperative mortal i ty.  The 30-day mortal i ty 
rate in extended resections was 7.5% (7 patients).  
Two patients died of  postoperat ive sepsis with mul- 
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Table V. Postoperative complications 
Extended resections (n = 94) Nonextended resections (n = 32) 
n % n % p Value 
Complication by type 
Arrhythmia 22 
Myocardial infarction 2 
Congestive heart failure 2 
Secretory retention/atelectasis 15 
Respiratory insufficiency* 11 
Postoperative h morrhage (>3 units) 12 
Pneumonia 8 
Pleural empyema 2 
Bronchial stump insufficiency 5 
Wound infection 4 
Sepsis 2 
Recurrent nerve lesion 5 
Others (e.g., pericardial effusion) 11 
Total 67 
Patients with multiple complications 
1 Complication 38 
2 Complications 21 
3 Complications 6 
4 Complications or more 2 
Multiple total 29 
23 4 13 NS 
2 0 0 NS 
2 0 0 NS 
16 1 3 NS 
12 3 9 NS 
13 1 3 NS 
9 0 0 NS 
2 1 3 NS 
5 1 3 NS 
4 3 9 NS 
2 0 0 NS 
5 3 9 NS 
12 0 0 NS 
71 9 28 <0.002 
40.4 4 12.5 0.007 
22.3 4 12.5 NS 
6.4 0 0 NS 
2.1 1 3.1 NS 
30.8 5 15.6 NS 
*Defined as postoperative Po 2 < 60 mm Hg breathing ambient air. 
tiorgan failure, one patient died of postoperative 
hemorrhage, two patients died of postpneumonec- 
tomy adult respiratory distress yndrome, and two 
patients died of pneumonia. Two (6.3%) out of 32 
patients died after nonextended resections, both of 
respiratory failure. This difference was not statisti- 
cally significant. All patients who died had under- 
gone pneumonectomies. In the group of patients 
who underwent extended resection no difference 
was found in the 30-day mortality rate between the 
subgroups with a T3 tumor (n = 5, 7.8%) or T4 
tumor (n = 2, 6.7%). 
Postoperative complications (Table V). The 
postoperative course was uneventful in 27 (29%) 
patients, whereas 67 (71%) patients had complica- 
tions after extended resections. Nine (28%) patients 
had complic, ations after nonextended resections 
(p < 0.002 versus extended resections). In the group 
of patients who underwent extended resection o 
significant difference was found in the morbidity 
between the subgroups with a T3 tumor (n = 43, 
67%) or T4 tumor (n = 24, 80%) (p = 0.059). 
Atelectasis was considered a major complication if it 
necessitated more than one bronchoscopy proce- 
dure to reexpand the lobe or lung affected. 
Risk analysis 
Correlation of risks and complications. Correla- 
tion of risk factors and postoperative complications 
in patients undergoing extended resections i shown 
in Tables VI and VII. Analysis of postoperative 
deaths showed that the risk of dying after an ex- 
tended operation did not correlate with a history of 
respiratory disease, metabolic disease, chronic alco- 
hol abuse, history of cardiac disease, pulmonary 
function test results, or results of bicycle ergonom- 
etry. Moreover, the pulmonary or cardiac risk score 
did not enable prediction of the lethal outcome of 
an operation. Twenty-five percent of the patients in 
whom pneumonia developed ied of this complica- 
tion and 18% of those in whom respiratory insuffi- 
ciency developed ied. One of two patients who had 
an acute myocardial infarction died, whereas all 
patients who had arrhythmia or congestive heart 
failure survived. Patients older than 70 years tended 
to have a lower mortality and morbidity rate (0% 
and 58.3%, respectively) than younger patients 
(10% and 75.7%, respectively) (not significant). The 
type of surgical procedure done correlated with the 
mortality, with all postoperative d aths occurring in 
the group that underwent pneumonectomy. 
Cardiac complications. The development of post- 
operative tachyarrhythmias correlated with a history 
of coronary artery disease, pathologic ergonometry, 
and a high risk in the cardiac risk score (Tables VI 
and VII). Sixteen percent of the patients in the low 
cardiac risk group had cardiac complications com- 
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Table VI. Risk analysis in patients undergoing extended resections (cardiovascular complications) 
Myocardial Congestive Postoperative 
Complications infarction Arrhythmias heart failure hemorrhage 
Risk factors (n) (n = 2) (n = 22) (n = 2) (n = 12) 
Pathologic ergonometry 19 12 (p < 0.002) 4 
Myocardial infarction 2 1 
Hypertension* 32 2 11 1 5 
Myocardial insufficiency 5 1 1 2 
Coronary artery disease 12 1 6 (p = 0.049) 1 2 
Cardiac score 25 1 12 (p < 0.003) 1 5 
Age ->70 yr 24 1 6 1 4 
The numbers in columns reflect the number of patients with each risk factor in whom the mentioned complication developed. Many patients in whom 
complications developed had several risk factors. No significant association was found between cardiovascular complications and emphysema, COPD, 
pneumonia, cardiac history, arrhythmias, alcohol abuse, renal insufficiency, diabetes mellitus, elevated liver function test results, arterial Po;, Po2 increase 
under stress, pulmonary risk score I and II, FEV1, VCrel, FEVlr,1/VCr~I, or FEVlrel. VCrel, Relative vital capacity; FEVI~t, relative FEV~. 
*Defined as diastolic pressure ->90 mm Hg. 
Table VII. Risk analysis in patients undergoing extended resections (respiratory complications) 
Respiratory Atelectasis/ 
Complications Pneumonia insuficiency secretory Seropneumothorax Total 
Risk Factors (n) (n = 8) (n = 11) retention (n = 15) (n = 15) (n = 67) 
Emphysema 12 1 1 5 (p = 0.055) 8 
Pneumonia 8 1 1 4 
COPD 60 6 8 14 (p = 0.21) 9 47 
Pulmonary risk score I 
Intermediate risk 40 2 4 9 (p = 0.047) 8 28 
High risk 13 1 4 4 (p = 0.037) 4 12 
Pulmonary risk score II 
Intermediate risk 54 6 7 11 (p = 0.054) 9 41 
High risk 18 2 2 4 4 14 
FEVI* 
Intermediate risk 21 1 2 6 1 18 
High risk 7 2 1 4 6 
VCrel* 
Intermediate risk 20 2 7 4 14 
High risk 6 2 6 
FEVlr,I/VCr~It 56 5 6 9 11 39 
FEVlrel 
40%-50% 5 1 4 
<40% 0 
Age ->70 yr 24 1 4 4 14 
The numbers in columns reflect the number of patients with each risk factor in whom the mentioned complication developed. Many patients in whom 
complications developed had several risk factors. No significant association was found between respiratory complications and cardiac history, coronary artery 
disease, cardiac score, pathologic ergonometry, myocardial infarction, hypertension, cardiac history, myocardial insufficiency, arrhythmias, alcohol abuse, 
renal insufficiency, diabetes mellitus, elevated liver function test results, arterial Po2, or Po z increase under stress. VCrez, Relative vital capacity; FEVlreZ , 
relative FEV1. 
*As defined for the pulmonary risk score II. 
~'A ratio operation 0.7 was considered to indicate an increased risk. 
pared with 56% in the high cardiac risk group (p = 
0.011). 
Respiratory complications. The development of 
bronchial secretory retention or atelectasis was sig- 
nificantly correlated with a moderate or high pup 
monary risk score I and a history of COPD but not 
with pulmonary risk score II (Tables VI and VII). 
Of the respiratory parameters only FEV 1 tended to 
be lower in patients in whom bronchial secretory 
retentions developed (mean value 2.03 L versus 
2.37 L) (p = 0.069). In contrast development of 
pneumonia was not significantly correlated with the 
pulmonary risk scores or a history of metabolic 
disease. 
All other cardiac, pulmonary, or metabolic risk 
factors bore no relation to the development of 
postoperative complications. 
Survival. Analysis of survival showed a signifi- 
cantly superior 3-year survival of 58% for nonex- 
tended resections over extended resections with a 
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Fig. 1. Survival curves according to surgical procedure. *p < 0.05 versus extended resections. 
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Fig. 2. Survival curves after extended resections according to resection margins. *p < 0.05 versus R0 
resections. 
3-year survival of 27% (p = 0.04) (Fig. 1). This 
was no longer statistically significant when only 
patients having R0 resection were considered 
(p = 0.15). Patients with R0 resected tumors fared 
significantly better than patients with R1 or R2 
resected tumors, as expected (Fig. 2) (p = 0.02). 
Three-year survival was 33% in the R0 group 
versus 10% :in the R1/R2 group. Patients with R1 
resections had no better survival than patients 
with R2 resections (p = 0.14). In contrast, no 
significant difference was observed between T3 
and T4 tumors (Fig. 3). Although lymph node 
staging seemed to influence survival, this differ- 
ence did not reach statistical significance (Fig. 4). 
Pathologic proof of tumor invasion into adjacent 
organs was associated with a worse prognosis. In 
these patients the 3-year survival was 21% versus 
a 3-year survival of 36% in patients with inflam- 
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matory adherence (p = 0.035). The type of organ 
infiltrated did not influence survival. 
The extent of pulmonary resection had no influ- 
ence on survival among the patients who underwent 
extended resection. After extended pneumonec- 
tomy 3-year survival was 29.7% and after extended 
lobectomy 3-year survival was 32.6%. 
Discuss ion  
This study was designed to evaluate the merit of 
extended resections for locally advanced lung can- 
m 
• N2 
i ON0 
48 
resections according to N stage. 
cer. Twenty-nine percent of our patients with lung 
cancer who underwent resection had an extended 
procedure. We attribute this high percentage to two 
facts. First, we think that macroscopic adherence of 
a tumor to an adjacent structure demands an ex- 
tended resection. We do not try to verify tumor 
invasion by frozen section because of the risk of 
tumor dissemination] Second, in view of the natural 
history of locally advanced lung cancer with a 1-year 
survival of 5% l's we pursue a rather aggressive 
approach. Preoperative suspicion of invasion of 
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mediastinal organs is not considered a contraindica- 
tion for exploratory operation at our institution. 
This seems to be justified by the 3-year survival rates 
presented herein. 
The postoperative mortality rate for extended 
resections was 7.4% and for nonextended resections 
was 6.3%. This is well within the range of the 
expected mortality. 945 In our own experience in a 
series of 145 consecutive patients undergoing non- 
extended resection for T1 or T2 lung cancers the 
30-day mortality rate was 4.1% (not significant 
versus extended resections). Although the difference 
in postoperative mortality between extended and 
nonextended resections was not statistically signifi- 
cant the difference in postoperative morbidity was.
Postoperative morbidity tended to be somewhat 
elevated after resection for T4 lung cancers al- 
though this difference did not reach statistical sig- 
nificance. This increased risk concerned cardiopul- 
monary complications only, which account for the 
majority of principal complications after pulmonary 
resections. 16-19 The high risk of the development of 
one of these complications will influence the indica- 
tion for operation in many institutions because most 
extended resections are planned as extended resec- 
tions after preoperative staging by radiologic 
means. 5 It is therefore of particular interest to 
determine the risk factors that predispose for these 
complications and to analyze the outcome. The aim 
of this risk factor analysis was to either exclude 
certain patients from operation r to find particular 
precautions that could prevent complications. 
Risk factors that predisposed to complications 
were history of coronary artery disease, pathologic 
ergonometry, high risk in the cardiac risk score, 
COPD, and an elevated pulmonary risk score I. 
None of these risk factors predisposed to a lethal 
outcome so as to justify exclusion of a patient from 
operation. This may be a result, in part, of the rare 
occurrence of myocardial infarction and congestive 
heart failure. Of the 25 patients with an elevated 
cardiac score only 1 patient each had the develop- 
ment of myocardial infarction or congestive heart 
failure. Con~tplications that arose were usually man- 
aged conservatively with satisfactory success. The 
described extensive routine preoperative work-up 
should suffice to offer these patients the best diag- 
nostic and therapeutic management of their disease. 
A coronary angiogram should be reserved for pa- 
tients with pertinent coronary history and symp- 
toms. We stress, however, that this extensive pre- 
operative work-up and intensive postoperative 
surveillance is imperative in all patients undergoing 
resection for lung cancer. 
All patients who died in this study had undergone 
pneumonectomy. Nevertheless the aim to achieve 
R0 resections i of paramount importance consider- 
ing the poor outcome if locally advanced lung cancer 
is not resected. Because a 30% 3-year survival canbe 
achieved after extended resections even a 17% mor- 
tality rate in the pneumonectomy group should not 
deter the surgeon from potentially curative resection. 
In contrast o other studies, 1°' 20,21 we cannot 
propose a less aggressive approach in elderly pa- 
tients. In accordance with results of a recent report 22 
age neither predisposed the patient to a lethal 
outcome nor to complications despite acomparative 
spectrum of procedures done in the high percentage 
of elderly patients (Tables VI and VII). 
Three-year survivals of 27% after extended resec- 
tions and 3-year survivals after all resections for T3 
and T4 tumors of 25% and 22%, respectively, are 
well within the range of what is reported in the 
literature.9, 13,23-25 Although at this point we cannot 
give 5-year survival rates, it is of interest that as in 
this study survival curves tend to reach a plateau 
after 2 years. 9
No significant differences were observed between 
results in T3 and T4 stage cancers. In accordance 
with other reports 26 the differences seen between 
N0/N1 and N2 stages also did not reach statistical 
significance. This may be because of the limited 
number of patients in this study and could eventu- 
ally become significant with a longer follow-up. We 
presume, however, that this finding emphasizes the 
prognostic importance of locally advanced tumors. 
Larger series of patients will have to be evaluated to 
permit a definitive conclusion. With surgical resec- 
tion still offering the best hope for cure in lung 
cancer 27-31 and neoadjuvant therapy and radiation 
therapy still being evaluated, 32-34 the key to improv- 
ing treatment remains trying to resect without resid- 
ual tumor. 
We therefore trust that even elderly patients or 
patients with severe cardiopulmonary risk factors 
should not be excluded from the benefits of possibly 
curative operation. Postoperative mortality cannot 
be reduced by excluding on the basis of particular 
risk factors patients from operation who require 
extended resections. If a patient is considered to be 
eligible to undergo pulmonary resection, he or she 
can be considered to be eligible to undergo ex- 
tended pulmonary resection. However, improve- 
ment of preoperative and postoperative cardiopul- 
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monary care will increase the safety with which these 
procedures can be done. 
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